Genesis Drug Discovery & Development (GD3)
Genesis Drug Discovery & Development (GD3) Welcomes You!
Genesis Drug Discovery & Development (GD3) is a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-IIII clinical trials. GD3 portfolio includes services for HTS and assay development, synthetic organic and medicinal chemistry, DMPK/in-vivo pharmacology and safety pharmacology, toxicology as well as clinical trial services for the regulatory approval of novel drug and medical device products.
GD3 member companies have been advancing drug discovery and development with a niche in ocular drug development. We offer specialized ADME and ocular drug discovery models by using bioanalytical tandem mass spectrometry (MS/MS) method development, validation, sample analysis, and custom in vivo research models. We have expertise in specialized test article administration and micro-dissection of ocular tissues and development of cell lines for high throughput screening and target validation.
Brands: Member companies include PharmOptima in Portage, MI, Comparative Biosciences, Inc. in Sunnyvale, CA, Integrated Analytical Solutions (IAS) in Berkeley, CA.